Listed

Champions Oncology, Inc.: Form 10-K for the period ended Apr 30, 2015

Filed with the SEC on Jul 29, 2015 and accepted by EDGAR at Jul 29, 2015, 16:09 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-04-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2014-05-01 to 2015-04-30$4.8mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2014-05-01 to 2015-04-30−$13.2mus-gaap:OperatingIncomeLoss
Income tax12 months2014-05-01 to 2015-04-30$127.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2014-05-01 to 2015-04-30−$13.1mus-gaap:NetIncomeLoss
Diluted EPS12 months2014-05-01 to 2015-04-30−$0.18us-gaap:EarningsPerShareDiluted
Basic EPS12 months2014-05-01 to 2015-04-30−$0.18us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2014-05-01 to 2015-04-3077,092,923 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure12 months2014-05-01 to 2015-04-30$119.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-04-30$9.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-04-30$10.8mus-gaap:AssetsCurrent
Total assetsAt period end2015-04-30$12.0mus-gaap:Assets
Current liabilitiesAt period end2015-04-30$3.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-04-30$4.0mus-gaap:Liabilities
Shareholders' equityAt period end2015-04-30$8.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-15-044834. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.